Gene: IDH3G
Official Full Name: isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gammaprovided by HGNC
Gene Summary: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia. Several alternatively spliced transcript variants of this gene have been described, but only some of their full length natures have been determined. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37132 | IDH3G Knockout cell line (HeLa) | Human | IDH3G | 1:3~1:6 | Negative | Online Inquiry |
KO37133 | IDH3G Knockout cell line (HCT 116) | Human | IDH3G | 1:2~1:4 | Negative | Online Inquiry |
KO37134 | IDH3G Knockout cell line (HEK293) | Human | IDH3G | 1:3~1:6 | Negative | Online Inquiry |
KO37135 | IDH3G Knockout cell line (A549) | Human | IDH3G | 1:3~1:4 | Negative | Online Inquiry |
IDH3G Gene Knockout Cell Lines are meticulously engineered cellular models designed to explore the role of the isocitrate dehydrogenase 3 gamma gene (IDH3G) in various biological processes. These cell lines have been created using CRISPR/Cas9 technology to provide a precise genetic alteration that effectively silences the IDH3G gene, allowing researchers to investigate the functional consequences of this knockout on cellular metabolism and signaling pathways.
The primary function of the IDH3G Gene Knockout Cell Lines lies in their ability to facilitate in-depth studies of the metabolic changes that occur following the loss of IDH3G activity. IDH3G encodes an enzyme critical for the NAD+-dependent oxidation of isocitrate to alpha-ketoglutarate, an integral step in the tricarboxylic acid cycle. By utilizing these knockout cell lines, scientists can analyze altered metabolic profiles, the downstream effects on cellular growth, proliferation, and differentiation, and how these alterations may link to various cancers and metabolic disorders.
In clinical and research settings, understanding the implications of IDH3G loss provides valuable insights into tumor biology, particularly in relation to metabolic reprogramming in cancer cells. Furthermore, the IDH3G knockout models can serve as platforms for drug discovery, enabling researchers to test therapeutic compounds that target metabolic pathways, thereby propelling forward potential treatments and interventions.
What sets IDH3G Gene Knockout Cell Lines apart from traditional cell models is their precision, reproducibility, and the ease with which researchers can incorporate them into existing experimental frameworks. Unlike alternative models that may exhibit background expression or unanticipated off-target effects, these knockout lines provide a clean slate for investigation, ensuring that results are attributable to specific pathways affected by IDH3G deletion.
For researchers and clinicians dedicated to understanding the intricacies of cellular metabolism and its role in disease, IDH3G Gene Knockout Cell Lines represent an invaluable tool. With our company’s robust expertise in cell line development and genetic engineering, we are committed to delivering high-quality products that empower your research and advance the frontiers of science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.